AMPs show potential for the treatment of antibiotic-resistant infections but they still need to be optimized through chemical modifications, nanotechnology-based delivery systems, and bioengineering to enhance their safety, efficacy, and practicality for medical use [19,68]. This evidence concerns the gene ADSL and infection.